Dissemin is shutting down on January 1st, 2025

Published in

American Medical Association, Journal of the American Medical Association, 1(309), p. 48

DOI: 10.1001/jama.2012.153812

Lippincott, Williams & Wilkins, Survey of Anesthesiology, 5(57), p. 230-231, 2013

DOI: 10.1097/sa.0b013e3182a4929c

Links

Tools

Export citation

Search in Google Scholar

Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality

Journal article published in 2013 by Olof Stephansson, Helle Kieler, Bengt Haglund, Miia Artama ORCID, Anders Engeland, Kari Furu, Mika Gissler, Mette Norgaard, Rikke Beck Nielsen, Helga Zoega ORCID, Unnur Valdimarsdottir ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Maternal psychiatric disease is associated with adverse pregnancy outcomes. Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy has been associated with congenital anomalies, neonatal withdrawal syndrome, and persistent pulmonary hypertension of the newborn. However, the risk of stillbirth and infant mortality when accounting for previous maternal psychiatric disease remains unknown.